Sandoz S.R.L.
Sandoz S.R.L., a prominent player in the pharmaceutical industry, is headquartered in Romania (RO) and operates extensively across various regions. Founded in 2003, the company has established itself as a leader in the development and distribution of generic medicines and biosimilars, focusing on high-quality, affordable healthcare solutions. Sandoz S.R.L. is renowned for its diverse portfolio, which includes a wide range of therapeutic areas such as oncology, cardiovascular health, and infectious diseases. The company’s commitment to innovation and sustainability sets it apart in a competitive market, enabling it to meet the evolving needs of patients and healthcare providers alike. With a strong market position, Sandoz S.R.L. has achieved significant milestones, including numerous product launches and partnerships that enhance its reputation as a trusted provider of essential medications.
DitchCarbon Score
How does Sandoz S.R.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sandoz S.R.L.'s score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sandoz S.R.L.'s reported carbon emissions
Sandoz S.R.L., headquartered in Romania, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. Despite the absence of emissions data, Sandoz S.R.L. is committed to addressing climate change through various initiatives. However, no specific reduction targets or climate pledges have been disclosed. This lack of detailed information highlights the need for transparency in corporate climate commitments within the pharmaceutical industry. As the industry increasingly focuses on sustainability, Sandoz S.R.L. may benefit from establishing clear emissions reduction goals and reporting practices to align with global climate standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sandoz S.R.L. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
